These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26491690)

  • 1. Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome.
    Jensen LJ; Flyvbjerg A; Bjerre M
    Biomed Res Int; 2015; 2015():815942. PubMed ID: 26491690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
    Basta G; Del Turco S; Navarra T; Lee WM;
    Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I.
    Basta G; Del Turco S; Marchi F; Navarra T; Battaglia D; Mercuri A; Mazzone A; Berti S
    Coron Artery Dis; 2011 Dec; 22(8):590-4. PubMed ID: 22072229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
    Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
    Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
    Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
    Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
    PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.
    Grauen Larsen H; Yndigegn T; Marinkovic G; Grufman H; Mares R; Nilsson J; Goncalves I; Schiopu A
    Atherosclerosis; 2019 Aug; 287():16-23. PubMed ID: 31181415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.
    Caspar-Bell G; Dhar I; Prasad K
    Mol Cell Biochem; 2016 Mar; 414(1-2):171-8. PubMed ID: 26895319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble receptor for advanced glycation end products as a potential biomarker to predict weight loss and improvement of insulin sensitivity by a very low calorie diet of obese human subjects.
    Hagen I; Schulte DM; Müller N; Martinsen J; Türk K; Hedderich J; Schreiber S; Laudes M
    Cytokine; 2015 Jun; 73(2):265-9. PubMed ID: 25802195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating soluble receptor for advanced glycation end products is decreased and inversely associated with acute phase response in chronic spontaneous urticaria.
    Kasperska-Zajac A; Damasiewicz-Bodzek A; Tyrpień-Golder K; Zamlyński J; Grzanka A
    Inflamm Res; 2016 May; 65(5):343-6. PubMed ID: 26801062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.
    Yu SL; Wong CK; Szeto CC; Li EK; Cai Z; Tam LS
    Lupus; 2015 Jun; 24(7):675-86. PubMed ID: 25411258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic changes in sRAGE levels and relationship with cardiac function in STEMI patients.
    Jensen LJ; Lindberg S; Hoffmann S; Iversen AZ; Pedersen SH; Møgelvang R; Galatius S; Flyvbjerg A; Jensen JS; Bjerre M
    Clin Biochem; 2015 Mar; 48(4-5):297-301. PubMed ID: 25562186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome.
    Raposeiras-Roubín S; Rodiño-Janeiro BK; Paradela-Dobarro B; Grigorian-Shamagian L; García-Acuña JM; Aguiar-Souto P; Jacquet-Hervet M; Reino-Maceiras MV; González-Juanatey JR; Álvarez E
    PLoS One; 2013; 8(9):e74302. PubMed ID: 24058542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease.
    Wang X; Xu T; Mungun D; Zhou C; Zha Z; Lu M; Fen C; Guo Y
    Dis Markers; 2019; 2019():4528382. PubMed ID: 31275446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble receptor for advanced glycation end products and coronary atherosclerosis: possible correlation with clinical presentation.
    Falcone C; Bozzini S; D'Angelo A; Matrone B; Colonna A; Benzi A; Paganini EM; Falcone R; Pelissero G
    Dis Markers; 2013; 35(3):135-40. PubMed ID: 24167358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study.
    Jabaudon M; Hamroun N; Roszyk L; Guérin R; Bazin JE; Sapin V; Pereira B; Constantin JM
    Intensive Care Med; 2015 May; 41(5):846-55. PubMed ID: 25792206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.